Additional experiments are needed to determine the impact of Srebp1c downregulation and to disentangle the seemingly paradoxical relationship between elevated levels of ACSL4 and poor HCC prognosis [57], alongside the role for ACSL4 in PUFA activation and increased sensitization to ferroptosis [58]. The gene discussed is SREBF1; the disease is hepatocellular carcinoma.